Light Mode
$18.25 ↑ +0.00 (+0.00%) Trading Up from the previous close of $18.25, $0.74 below the day’s high of $18.99
-4.15 (-18.53%) / 6M
Momentum, market sentiment, and recent alerts
CTY reads n/a: the 12-month move is -18.5%.
No alerts for CTY in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
City Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the development of RNAi therapeutics. The company was founded by John Maraganore, Sebastian Trousil, Ari Nowacek, Mark Keating, Kotaro Nakanishi, Yukihide Tomari, and Phillip Zamore on July 17, 2023 and is headquartered in Cambridge, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.